Related Experiment Video
Updated: Jul 15, 2026

07:39
Mouse In Vivo Placental Targeted CRISPR Manipulation
Published on: April 14, 2023
Induction of abortion during midgestation in mares
The Canadian Veterinary Journal = La Revue Veterinaire Canadienne
|December 1, 1982
Summary
Prostalene treatment in pregnant mares did not induce abortion. However, it caused cervical relaxation and uterine changes, preparing them for subsequent abortion induction with hypertonic saline without complications.
Area of Science:
- Veterinary Medicine
- Reproductive Biology
Background:
- Prostaglandins are crucial for reproductive processes, including luteolysis and parturition.
- Synthetic prostaglandin analogues are used in veterinary medicine for reproductive management.
Purpose of the Study:
- To evaluate the efficacy of prostalene, a synthetic prostaglandin analogue, in inducing abortion in pregnant standardbred mares.
- To assess the physiological effects of prostalene administration on the reproductive tract and progesterone levels.
Main Methods:
- Four pregnant standardbred mares (99-153 days gestation) were administered varying doses of prostalene via subcutaneous injection.
- Physiological parameters including cervical tone, uterine tone, and plasma progesterone concentrations were monitored.
- Abortions were subsequently induced using intrauterine infusions of warm hypertonic saline if not achieved by prostalene.
Main Results:
- Prostalene administration resulted in cervical relaxation and increased uterine tone.
- A decrease in plasma progesterone concentrations was observed post-treatment.
- None of the mares aborted spontaneously within seven days of prostalene treatment.
- All mares subsequently aborted following intrauterine hypertonic saline infusion.
Conclusions:
- Prostalene alone is not sufficient to induce abortion in mid-term pregnant mares.
- Prostalene treatment may prepare the uterus for subsequent abortion induction.
- Warm hypertonic saline infusions are an effective method for inducing abortion in mares following prostalene treatment, with no observed complications.
